Name: Latest research reports of Zydus Lifesciences Ltd. authored by ICICI Securities Limited and published by - Trendlyne research reports.
Item: Zydus Lifesciences Ltd.
Rating: 5
Author: ICICI Securities Limited

Zydus Lifesciences Ltd.

NSE: ZYDUSLIFE | BSE: 532321 | ISIN: INE010B01027 | Industry: Pharmaceuticals
| Mid-range Performer

993.4500 -1.00 (-0.10%)

NSE Oct 10, 2025 15:31 PM

Volume: 1.6M

Zydus Lifesciences Ltd.

16 May 2016

993.45

-0.10%

Cadila Healthcare Limited

Buy: Zydus Lifesciences Ltd.

Target

ICICI Securities Limited

ICICI Securities Ltd | Retail Equity Research Revenues grew 7% YoY to | 2449.1 crore (I-direct estimate: | 2488.8 crore) driven by 12.9% YoY in India to | 767.4 crore (I-direct...

Zydus Lifesciences Ltd. is trading above its 200 day SMA of 949.7